Literature DB >> 16876854

Comorbidity between and risk factors for severe hearing and memory impairment in older Americans.

Yanfeng Li1, Eric W Healy, J Wanzer Drane, Jian Zhang.   

Abstract

OBJECTIVE: Comorbidities complicate our understanding of impairments and their risk factors. The objective of the current study was to assess the comorbidity between hearing impairment (HI) and memory impairment (MI) in older Americans and to assess to what extent they share common risk factors.
METHOD: Data were examined from 5252 participants aged 65 years or older from the Third National Health and Nutrition Examination Survey (1988-1994).
RESULTS: The prevalence of HI and MI was 21.4 (SE 0.8)% and 8.3 (0.6)%, respectively, but the prevalence of concurrent impairment was only 2.1 (0.2)%. African Americans had higher odds of MI than whites (OR=3.75, 95% CI: 2.81, 5.00), but not of HI (OR=0.62, 95% CI: 0.42, 0.91). Leisure physical activity was associated with lower odds of MI, good lung function was associated with lower odds of HI, and moderate alcohol use was associated with lower odds of both HI and MI. Compared with individuals free of HI, the OR of MI was 1.07 (95% CI: 0.78, 1.47) for individuals with HI.
CONCLUSION: Although prevalence was relatively high, comorbidity was surprisingly low, and the two impairments were not significantly associated. In addition to age, other factors appear to play critical but different roles in the development of these impairments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876854     DOI: 10.1016/j.ypmed.2006.06.014

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  Biomarkers of Systemic Inflammation and Risk of Incident Hearing Loss.

Authors:  Shruti Gupta; Sharon G Curhan; Gary C Curhan
Journal:  Ear Hear       Date:  2019 Jul/Aug       Impact factor: 3.570

2.  Assessment of sensory function in the National Social Life, Health, and Aging Project.

Authors:  L Philip Schumm; Martha McClintock; Sharon Williams; Sara Leitsch; Johan Lundstrom; Thomas Hummel; Stacy Tessler Lindau
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-06-23       Impact factor: 4.077

3.  Duration of Analgesic Use and Risk of Hearing Loss in Women.

Authors:  Brian M Lin; Sharon G Curhan; Molin Wang; Roland Eavey; Konstantina M Stankovic; Gary C Curhan
Journal:  Am J Epidemiol       Date:  2016-12-14       Impact factor: 4.897

4.  Cigarette Smoking, Smoking Cessation, and Risk of Hearing Loss in Women.

Authors:  Brian M Lin; Molin Wang; Konstantina M Stankovic; Roland Eavey; Michael J McKenna; Gary C Curhan; Sharon G Curhan
Journal:  Am J Med       Date:  2020-05-07       Impact factor: 4.965

5.  Skin Pigmentation and Risk of Hearing Loss in Women.

Authors:  Brian M Lin; Wen-Qing Li; Sharon G Curhan; Konstantina M Stankovic; Abrar A Qureshi; Gary C Curhan
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

6.  Analgesic use and the risk of hearing loss in women.

Authors:  Sharon G Curhan; Josef Shargorodsky; Roland Eavey; Gary C Curhan
Journal:  Am J Epidemiol       Date:  2012-08-29       Impact factor: 4.897

7.  Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.

Authors:  Brian M Lin; Sharon G Curhan; Molin Wang; Brian C Jacobson; Roland Eavey; Konstantina M Stankovic; Gary C Curhan
Journal:  Ear Hear       Date:  2017 Jan/Feb       Impact factor: 3.570

8.  Analgesic use and the risk of hearing loss in men.

Authors:  Sharon G Curhan; Roland Eavey; Josef Shargorodsky; Gary C Curhan
Journal:  Am J Med       Date:  2010-03       Impact factor: 4.965

9.  Prospective study of alcohol use and hearing loss in men.

Authors:  Sharon G Curhan; Roland Eavey; Josef Shargorodsky; Gary C Curhan
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

10.  Hypertension, Diuretic Use, and Risk of Hearing Loss.

Authors:  Brian M Lin; Sharon G Curhan; Molin Wang; Roland Eavey; Konstantina M Stankovic; Gary C Curhan
Journal:  Am J Med       Date:  2015-11-30       Impact factor: 4.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.